Brazil's ANVISA to beef up international inspections

4 April 2013

The operations of Brazil’s National Health Surveillance Agency, ANVISA, in international inspections are to be bolstered by local and state health inspectors. As of now, Agency inspections in factories located abroad may be performed by local public health servants trained in Good Manufacturing Practices.

ANVISA Ordinance No 571/2013 provides a list of names of servants operating in the National Health Surveillance System (SNVS), based in local and state health surveillance agencies, who are able to participate in international inspection teams for the agency in medicines, pharmaceutical ingredients and health products.

Decree No 7930/2013, published in February this year, opened the possibility of servants from other federal agencies participating in international inspection teams set up by ANVISA. Based on the Decree, ANVISA published the Ordinance which provides a new opportunity for training local health inspectors in the field and extends the capacity to perform inspections in factories located in other countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical